A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors
Titel:
A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound in patients with refractory solid tumors
Auteur:
Simon, George R. Ilaria, Robert L. Sovak, Mika A. Williams, Charles C. Haura, Eric B. Cleverly, Ann L. Sykes, Amanda K. Wagner, Margaret M. de Alwis, Dinesh P. Slapak, Christopher A. Miller, Mary A. Spriggs, David R.